Princeton, New Jersey, November 10, 2021 – RxLogix Corporation, a global leading provider of end-to-end Safety and Pharmacovigilance (PV) Software and Services, today announced the Go-Live of FAERS II at the United States Food and Drug Administration (FDA). FAERS II utilizes the RxLogix integrated PV signaling platform consisting of PV Signal, PV Reports, and PV Analytics. […]
Amsterdam, Netherlands, December 7th 2023 — RxLogix Corporation, a global leading provider of end-to-end Safety and Pharmacovigilance (PV) Software and Services, is delighted to announce a strategic software agreement with the European Medicines Agency (EMA) to begin the development of the new Signal and Safety Analytics (SSA) platform. The SSA platform, which will include RxLogix […]
RxLogix provides the industry's best solutions to the ever-changing drug safety & pharmacovigilance
BOOK A DEMOSubscribe to our newsletter and learn the latest news from RxLogix.
Information on RxLogix Products – info@rxlogix.com
RFI and RFP Response Request – sales@rxlogix.com
Sales Inquiries – sales@rxlogix.com
Marketing Inquiries – marketing@rxlogix.com
Career Opportunities – careers@rxlogix.com
